Solaisia Financial Results Grayscale Technologies & Science CAICA

Sorrizia Pharma announced its IFRS financial results after the close of trading on February 9 (15:30). For the fiscal year ending December 2021, the consolidated net loss was 2.47 billion yen, narrowing from a loss of 4.12 billion yen in the previous year, and for the fiscal year ending December 2022, the company expects a net loss of 570 million yen, with the loss narrowing further. It will be 12 consecutive years of losses.